Association of Liver Hemangiosarcoma and Secondary Iron Overload in B6C3F1 Mice - The National Toxicology Program Experience

Toxicologic Pathology

Volumn 32, Issue 2, 2004, Pages 222-228

  Nyska, Abraham ^a   Haseman, Joseph K ^a   Kohen, Roni ^b   Maronpot, Robert R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Hemangiosarcoma; Hemolysis; Hemosiderin; Liver; Mouse

Indexed keywords

2 BUTOXYETHANOL; 4 CHLOROANILINE; 4 NITROANILINE; 4 NITROANISOLE; HEMOSIDERIN; PENTACHLOROPHENOL; TETRAFLUOROETHYLENE;

ANGIOSARCOMA; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; DISEASE PREDISPOSITION; ENZYME REGULATION; ERYTHROCYTE; FEMALE; GENDER; HEMOLYSIS; HEMOSIDEROSIS; INCIDENCE; IRON OVERLOAD; KUPFFER CELL; LIVER HEMANGIOSARCOMA; LIVER TUMOR; MALE; MOUSE; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL;

ANILINE COMPOUNDS; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; COCARCINOGENESIS; ETHYLENE GLYCOLS; FEMALE; HEMANGIOSARCOMA; HEMOLYSIS; HEMOSIDERIN; HEMOSIDEROSIS; IRON; KUPFFER CELLS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; NATIONAL INSTITUTES OF HEALTH (U.S.); SEX FACTORS; UNITED STATES;

ANIMALIA;

EID: 1842561699     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490274371     Document Type: Article

References (55)

1. Armitage, P. (1971). Statistical Methods in Medical Research. Wiley, New York.
2. Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C. J., and Holsboer, F. (1997). Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51, 535-41.
3. Black, J. (1981). Mineral metabolism. In Biological Performance of Materials: Fundamentals of Biocompatibility. Biomedical Engineering and Instrumentation (vol. 8, R. Plonsey and J. L. Katz, eds.), pp. 158-68. Marcel Dekker, New York.
4. Boelsterli, U. A. (2003). Immune mechanisms. In Mechanistic Toxicology (U. A. Boelsterli, ed.), pp. 212-36. Taylor & Francis, London and New York.
5. Bus, J. S., and Popp, J. A. (1987). Perspectives on the mechanism of action of the splenic toxicity of aniline and structurally-related compounds. Food Chem Toxicol 25, 619-26.
6. Comporti, M., Signorini, C., Buonocore, G., and Ciccoli, L. (2002). Iron release, oxidative stress and erythrocyte ageing. Free Radi Biol Med 32, 568-76.
7. Da Costa, L., Willig, T. N., Fixler, J., Mohandas, N., and Tchernia, G. (2001). Diamond-Blackfan anemia. Curr Opin Pediatr 13, 10-15.
8. Elliott, B. M., and Ashby, J. (1997). Review of the genotoxicity of 2-butoxyethanol. Mutat Res 387, 89-96.
9. Ernst, H., Carlton, W. W., Courtney, C., Rinke, M., Greaves, P., Isaacs, K. R., Krinke, G., Konishi, G., Mesfin, G. M., and Sandusky, G. (2001). Soft tissue and skeletal muscle. In The Mouse. International Classification of Rodent Tumors (U. Mohr, ed., pp. 365-6. Springer, Berlin.
10. Fracanzani, A. L., Conte, D., Fraquelli, M., Taioli, E., Mattioli, M., Losco, A., and Fargion, S. (2001). Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 33, 647-51.
11. Ghanayem. B. I., and Sullivan, C. A. (1993). Assessment of the haemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans. Hum Exp Toxicol 12, 305-11.
12. Goodman, D. G., Ward, J. M., and Reichardt, W. D. (1984). Splenic fibrosis and sarcomas in F344 rats fed diets containing aniline hydrochloride, p-chloroaniline, azobenzene, o-toluidine hydrochloride, 4,4′ -sulfonyldianiline, or D & C red No. 9. J Natl Cancer Inst 73, 265-73.
13. Haddow, A. (1960). On the carcinogenicity of an iron-dextran complex. J Natl Cancer Inst 24, 109-47.
14. Hann, H. W., Stahlhut, M. W., and Blumberg, B. S. (1988). Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res 48, 4168-70.
15. Haseman, J. K., Hailey, J. R., and Morris, R. W. (1998). Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol 26, 428-41.
16. Janov, A. J., Leong, T., Nathan, D. G., and Guinan, E. C. (1996). Diamond-Blackfan anemia. Natural history and sequelae of treatment. Medicine (Baltimore) 75, 77-8.
17. Kakhlon, O., and Cabantchik, Z. I. (2002). The labile iron pool: characterization, measurement, and participation in cellular processes. Free Rad Biol Med 33, 1037-46.
18. Kohen, R., and Nyska, A. (2002). Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 31, 620-50.
19. Kwittken, J., and Tartow, L. R. (1966). Haemochromatosis and Kupffer-cell sarcoma with unusual localisation of iron. J Pathol Bacteriol 92, 571-3.
20. Le, N. T., and Richardson, D. R. (2002). The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603, 31-46.
21. Leal, A. M., Begona Ruiz-Larrea, M., Martinez, R., and Lacort, M. (1998). Cytoprotective actions of estrogens against tert-butyl hydroperoxide-induced toxicity in hepatocytes. Biochem Pharmacol 56, 1463-9.
22. Lipton, J. M., Federman, N., Khabbaze, Y., Schwartz, C. L., Hilliard, L. M., Clark, J. I., and Vlachos, A. (2001). Diamond-Blackfan Anemia Registry osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 23, 39-44.
23. Manna, S. K., and Aggarwal, B. B. (1999). Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-κB activation and reactive oxygen intermediates. J Immunol 162, 1510-8.
24. National Cancer Institute (1978). NCI Bioassay of nitrofen for possible carcinogenicity. (CAS No. 1836-75-5) in Osborne-Mendel Rats and B6C3F1 Mice (Feed Studies. NCI Tech Rep Ser No. 26.
25. National Toxicology Program (1989A). NTP Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures (CAS No. 87-86-5) in B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 349, 1-265.
26. National Toxicology Program (1989B). NTP Toxicology and Carcinogenesis Studies of Para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 351, 1-256.
27. National Toxicology Program (1992A). Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 407, 1-289.
28. National Toxicology Program (1992B). NTP Technical Report on the Toxicology and Carcinogenesis Studies of 2,4-Diaminophenol Dihydrochloride (CAS NO. 137-09-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 401, 1-232.
29. National Toxicology Program (1993A). Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies). Natl Toxicol Program Tech Rep Ser 402, 1-286.
30. National Toxicology Program (1993B). NTP Toxicology and Carcinogenesis Studies of O-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 416, 1-482.
31. National Toxicology Program (1993C). NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 414, 1-284.
32. National Toxicology Program (1993D). NTP Toxicology and Carcinogenesis Studies of P-Nitroaniline (CAS No. 100-01-6) in B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 418, 1-203.
33. National Toxicology Program (1997). NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser 450, 1-321.
34. National Toxicology Program (2000). NTP Toxicology and Carcinogenesis Studies 2- Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser 484, 1-290.
35. Park, J., Kamendulis, L. M., and Klaunig, J. E. (2002). The effect of 2-butoxyethanol on morphological transformation in Syrian hamster embryo (SHE) cells. Toxicol Sci 68, 43-50.
36. Porreca, E., Ucchino, S., Di Febbo, C., Di Bartolomeo, N., Angelucci, D., Napolitano, A. M., Mezzetti, A., and Cuccurullo, F. (1994). Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb 14, 299-304.
37. Rakba, N., Loyer, P., Gilot, D., Delcros, J. G., Glaise, D., Baret, P., Pierre, J. L., Brissot, P., and Lescoat, G. (2000). Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines. Carcinogenesis 21, 943-51.
38. Richmond, H. G. (1959). Induction of sarcoma in the rat by iron-dextran complex. Br Med J 1, 947-9.
39. Rose, M. L., Germolec, D. R., Schoonhoven, R., and Thurman, R. G. (1997). Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18, 1453-6.
40. Rubin, E., and Farber, J. L. (1988). The liver. In Pathology, 2nd ed. (E. Rubin and J. L. Farber, eds.), pp. 704-85. Lippincott Company, Philadelphia.
41. Sack, M. N., Rader, D. J., and Cannon, R. O. III (1994). Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343, 269-70.
42. Selby, J. V., and Friedman, G. D. (1988). Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer 41, 677-82.
43. Shuangshoti, S., and Thaicharoen, A. (1994). Hepatocellular adenoma in a beta-thalassemic woman having secondary iron overload. J Med Assoc Thai 77, 108-12.
44. Siesky, A. M., Kamendulis, L. M., and Klaunig, J. E. (2002). Hepatic effects of 2-butoxyethanol in rodents. Toxicol Sci 70, 252-60.
45. Stevens, R. G., Graubard, B. I., Micozzi, M. S., Neriishi, K., and Blumberg, B. S. (1994). Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56, 364-9.
46. Stevens, R. G., Jones, D. Y., Micozzi, M. S., and Taylor, P. R. (1988). Body iron stores and the risk of cancer. N Engl J Med 319, 1047-52.
47. Tam, N. N., Ghatak, S., and Ho, S. M. (2003). Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats. Prostate 55, 1-8.
48. Toyokuni, S. (1996). Iron-induced carcinogenesis: the role of redox regulation. Free Rad Biol Med 20, 553-66.
49. Toyokuni, S. (2002). Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rept 7, 189-97.
50. Toyokuni, S., Tanaka, T., Nishiyama, Y., Okamoto, K., Nakashima, Y., Hamazaki, S., Okada, S., and Hiai, H. (1996). Induction of renal cell carcinoma in male Wistar rats treated with cupric nitrilotriacetate. Lab Invest 75, 239-48.
51. Weinberg, E. D. (1983). Iron in neoplastic disease. Nutr Cancer 4, 223-33.
52. Weinberg, J. B., and Hibbs, J. B. Jr. (1977). Endocytosis of red blood cells or haemoglobin byactivated macrophages inhibits their tumoricidal effect. Nature 269, 245-7.
53. Weinberger, M. A., Albert, R. H., and Montgomery, S. B. (1985). Splenotoxicity associated with splenic sarcomas in rats fed high doses of D & C Red No. 9 or aniline hydrochloride. J Natl Cancer Inst 75, 681-90.
54. Welch, K. D., Davis, T. Z., Van Eden, M. E., and Aust, S. D. (2002). Deleterious iron-mediated oxidation of biomolecules. Free Rad. Biol Med 32, 577-83.
55. Zurlo, M. G., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Piga, A., Melevendi, C., Di Gregorio, F., Burattini, M. G., and Terzoli, S. (1989). Survival and causes of death in thalassaemia major. Lancet 2, 27-30.